Posts by PacConAdmin

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. Source: FDA Press Releases

The FDA approved a new treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 12 years of age and older with hemophilia A or B, both without inhibitors. Source: FDA Press Releases

During the last decade, MRI techniques have been developed which allow noninvasive detection and quantitation of iron in body tissues such as liver, heart, and pancreas. Quantitation of cardiac iron is especially important, as this is the key predictor of cardiac dysfunction and these measurements inform decisions about the effectiveness of iron chelation therapy. As…

U.S. District Court for the Eastern District of California entered a consent decree of permanent injunction against Rizo Lopez Foods Inc. prohibiting the company from manufacturing and selling certain food products until the company complies with the FD&C Act and other federal regulations. Source: FDA Press Releases

Latin America’s genetic diversity and unique health challenges are driving groundbreaking clinical research, offering new insights into disease prevention, innovative medicine, and treatments. This collaboration not only benefits the region but also enriches global healthcare, showcasing the critical role Latin America plays in advancing medical advancements worldwide. The rich exchange of medical knowledge between Latin…

Princeton, NJ – October 8, 2024 – WCG, the global leader in providing solutions that measurably improve the quality and efficiency of clinical research, today released the WCG 2024 Clinical Research Site Challenges Report. The report features the latest data and insights from clinical research sites about the most significant challenges impacting those sites today. …

FDA granted marketing authorization for the Healgen Rapid Check COVID-19/Flu A&B Antigen Test Source: FDA Press Releases

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. Source: FDA Press Releases

Rheumatoid arthritis (RA) is the most common of the inflammatory arthropathies, affecting nearly 1% of the population with a female preponderance. Onset is typically between 45 and 65 years of age. While the etiology RA is unknown, it is thought to be largely autoimmune. Lack of treatment results in rapid progression of disease with significant…

In this episode of WCG Talks Trials, host Kelly FitzGerald sits down with Dr. Currien MacDonald, medical chair director at WCG, and Sara Reed, a participant in two psychedelic clinical trials, to explore the evolving landscape of psychedelics research. Dr. MacDonald shares his expertise on the growing acceptance of psychedelics in clinical settings, recent FDA updates,…